Ahlkvist, L., Omar, B., Pacini, G
A 2022 scientific review published in the National Library of Medicine confirmed that nasal delivery of therapeutic peptides is a non-invasive and fast-acting method that can effectively bypass the blood-brain barrier while minimising systemic exposure
It's designed to help people using GLP-1 medications track their doses while also monitoring symptoms, better understanding their progress over time, and providing clinicians' advice when it's needed most
424 Moreover, the two components of the G3P shuttle (including GPD1 in the cytoplasm and GPD2 in the mitochondria) are up-regulated in mRNA and protein levels in diabetic islets, thus ensuring the transfer of electrons from NADH produced in glycolysis to mitochondria
Lets wait to see stats
For those who have attempted diet, exercise, or even surgery to no avail, it might be a promising alternative